✦ LIBER ✦

Use of Nafamostat Mesilate and Gabexate Mesylate in the Prevention of Post-ERCP Pancreatitis and Risk Factor Analysis: A Prospective, Randomized Trial

✍ Scribed by Cheol Woong Choi; Dae Hwan Kang; Gwang-Ha Kim; Geun-Am Song; Jae-Sup Eum; Sang-Yong Lee; Hyoung-Yoel Park

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nafamostat mesylate in the prevention of

✍ Cheol Woong Choi; Dae Hwan Kang; Gwang Ha Kim; Jae Sup Eum; Sun Mi Lee; Geun Am 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Nafamostat Mesilate in the Prevention of

✍ Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Chan Ho Park; Yong Mock Bae; Sa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Comparison between ulinastatin and gabex

✍ Toshiharu Ueki; Keisuke Otani; Kenichiro Kawamoto; Aiko Shimizu; Naruhito Fujimu 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 162 KB

Efficacy of diclofenac in the prevention

✍ Young Koog Cheon; Kwang Bum Cho; James L. Watkins; Lee McHenry; Evan L. Fogel; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Gabexate mesylate in the prevention of p

✍ Ming-Hua Zheng; Jian-Ling Bai; Mao-Bin Meng; Yong-Ping Chen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Endoscopic sphincterotomy by using pure-

✍ Donald G. MacIntosh; Jonathan Love; Neena S. Abraham 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 137 KB